The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells
C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition - ScienceDirect
The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells
NCT-58 - ZellBio GmbH
Recent advances toward the development of Hsp90 C-terminal inhibitors - ScienceDirect
Biomolecules, Free Full-Text
Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances - ScienceDirect
Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
Cancers, Free Full-Text
Soeun Park's research works Korea University, Seoul (KU) and other places
Cancers, Free Full-Text
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells
Detailed curriculum vitae of HER2-targeted therapy - ScienceDirect
Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation